Clinical Application and Immune Infiltration Landscape of Stemness-Related Genes in Heart Failure
Authors:
Open Access
- 14 September 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (1) , 250-270
Abstract
Background: Heart failure (HF) is the leading cause of morbidity and mortality worldwide. Stemness refers to the self-renewal and differentiation ability of cells. However, little is known about the heart’s stemness properties. Thus, the current study aims to identify putative stemness-related biomarkers to construct a viable prediction model of HF and characterize the immune infiltration features of HF. Methods: HF datasets from the Gene Expression Omnibus (GEO) database were adopted as the training and validation cohorts while stemness-related genes were obtained from GeneCards and previously published papers. Feature selection was performed using two machine learning algorithms. Nomogram models were then constructed to predict HF risk based on the selected key genes. Moreover, the biological functions of the key genes were evaluated using Gene Ontology (GO) and Kyoto Encyclopedia of Genes Genomes (KEGG) pathway analyses, and gene set variation analysis (GSVA) and enrichment analysis (GSEA) were performed between the high- and low-risk groups. The immune infiltration landscape in HF was investigated, and the interaction network of key genes was analysed to predict potential targets and molecular mechanisms. Results: Seven key genes, namely SMOC2, LUM, FNDC1, SCUBE2, CD163, BLM and S1PR3, were included in the proposed nomogram. This nomogram showed good predictive performance for HF diagnosis in the training and validation sets. GO and KEGG analyses revealed that the key genes were primarily associated with ageing, inflammatory processes and DNA oxidation. GSEA and GSVA identified various inflammatory and immune signalling pathways that were enriched between the high- and low-risk groups. The infiltration of 15 immune cell subsets suggests that adaptive immunity has an important role in HF. Conclusions: Our study identified a clinically significant stemness-related signature for predicting HF risk, with the potential to improve early disease diagnosis, optimize risk stratification and provide new strategies for treating patients with HF.Keywords
Funding Information
- Natural Science Foundation of Gansu Province (22JR5RA665)
- Natural Science Foundation of Gansu Province (22JR5RA665)
This publication has 82 references indexed in Scilit:
- Pioneering therapies for post-infarction angiogenesis: Insight into molecular mechanisms and preclinical studiesBiomedicine & Pharmacotherapy, 2023
- A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysisCancer Communications, 2020
- Temporal Patterns of Macrophage- and Neutrophil-Related Markers are Associated with Clinical Outcome in Heart Failure PatientsESC Heart Failure, 2020
- Loss of P53 regresses cardiac remodeling induced by pressure overload partially through inhibiting HIF1α signaling in miceBiochemical and Biophysical Research Communications, 2018
- Stem Cell Therapy: A New Therapeutic Option for Cardiovascular DiseasesJournal of Cellular Biochemistry, 2017
- Role of Adaptive Immunity in the Development and Progression of Heart Failure: New EvidenceArchives of Medical Research, 2017
- Lumican -null mice are susceptible to aging and isoproterenol-induced myocardial fibrosisBiochemical and Biophysical Research Communications, 2017
- Increased Serum Levels of the Notch Ligand DLL1 Are Associated With Diastolic Dysfunction, Reduced Exercise Capacity, and Adverse Outcome in Chronic Heart FailureJournal of Cardiac Failure, 2016
- Pathophysiology of Heart Failure2015
- Exaggerated Inflammation and Monocytosis Associate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction: Evidence of M2 Macrophage Activation in Disease PathogenesisJournal of Cardiac Failure, 2015